Close Menu

Australian researchers led by Cathy Jensen looked into whether SNPs associated with risk of multiple sclerosis also affect the severity of the disease. To do so, they genotyped seven SNPs in more than a thousand people with MS and correlated that with clinical outcome measures such as age of onset, MS severity score, and the time interval between first demyelinating event and first relapse. The researchers found no association between those clinical outcomes and the SNPs under study.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.